[1]孙晶莹,李 研,黄晓燕,等.链霉亲和素-人粒细胞巨噬细胞集落刺激因子融合蛋白的制备与活性鉴定[J].陕西医学杂志,2023,52(1):3-6,22.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.001]
　SUN Jingying,LI Yan,HUANG Xiaoyan,et al.Preparation and bioactivity evaluation of SA-hGM-CSF fusion protein[J].,2023,52(1):3-6,22.[doi:DOI:10.3969/j.issn.1000-7377.2023.01.001]
点击复制

链霉亲和素-人粒细胞巨噬细胞集落刺激因子融合蛋白的制备与活性鉴定
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年1期
页码:
3-6,22
栏目:
基础研究
出版日期:
2023-01-05

文章信息/Info

Title:
Preparation and bioactivity evaluation of SA-hGM-CSF fusion protein
作者:
孙晶莹1; 2; 李 研1; 2; 黄晓燕1; 2; 靳占奎3; 徐翠香1; 2; 常 乐1; 2; 王建华4
(1.陕西省人民医院感染与免疫疾病重点实验室,陕西 西安 710068; 2.陕西省细胞免疫工程技术研究中心,陕西 西安 710068; 3.陕西省人民医院骨科,陕西 西安 710068; 4.陕西省人民医院普外二科,陕西 西安 710068)
Author(s):
SUN Jingying; LI Yan; HUANG Xiaoyan; JIN Zhankui; XU Cuixiang; CHANG Le; WANG Jianhua
(Key Laboratory of Infection and Immunity,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
关键词:
人粒细胞巨噬细胞集落刺激因子;  链霉亲和素;  融合蛋白;  蛋白纯化;  表达载体构建;  蛋白活性鉴定
Keywords:
Human granulocyte macrophage colony stimulating factor;  Streptavidin;  Fusion protein;  Protein purification;  Vector construction;  Identification of protein activity
分类号:
R 329.2
DOI:
DOI:10.3969/j.issn.1000-7377.2023.01.001
文献标志码:
A
摘要:
目的:制备链霉亲和素(SA)连接的人粒细胞巨噬细胞集落刺激因子(hGM-CSF)融合蛋白(SA-hGM-CSF),并对其生物学活性进行鉴定。方法:在NCBI数据库中查找SA和hGM-CSF序列,将序列合成后连接入Pet28表达载体中,构建SA-hGM-CSF-Pet28重组表达载体,在BL21(DE3)表达感受态中利用IPTG诱导剂诱导表达,经His镍柱纯化,尿素梯度复性,聚丙烯酰胺凝胶电泳法和蛋白质印迹法(WB)鉴定融合蛋白,通过TF-1细胞检测融合蛋白的生物学活性。结果:SA-hGM-CSF融合蛋白可在BL21(DE3)中高效诱导表达,经His镍柱纯化后该融合蛋白纯度较高。经尿素梯度复性后,细胞学实验验证该融合蛋白具有生物学活性。结论:成功表达具有生物活性的融合蛋白SA-hGM-CSF,该结果为SA-hGM-CSF表面锚定修饰的肿瘤细胞疫苗的研究提供了实验基础。
Abstract:
Objective:To prepare the streptavidin-tag hGM-CSF fusion protein SA-hGM-CSF,and to identify its biological activity.Methods:The sequences of SA and hGM-CSF were found in NCBI,and the sequences were synthesized and connected to Pet28 expression vector to construct the recombinant expression vector of SA-hGM-CSF-Pet28,which was induced by IPTG inducer in BL21(DE3)expression induced state,purified by His nickel column.After renaturation by urea gradient,the fusion proteins were identified by SDS-PAGE and Western blot.The biological activity of the fusion proteins was detected by TF-1 cells.Results:The fusion protein of SA-hGM-CSF could be efficiently induced in BL21(DE3),and the purity of the fusion protein was high after His nickel column purification.After urea gradient renaturation,cytological experiments verified the biological activity of the fusion protein.Conclusion:The fusion protein SA-hGM-CSF was successfully expressed,which provides experimental basis for the study of tumor cell vaccine modified by surface anchoring of SA-hGM-CSF.

参考文献/References:

[1] Mehta HM,Malandra M,Corey SJ.G-CSF and GM-CSF in neutropenia[J].J Immunol,2015,195(4):1341-1349.
[2] 周 艺,杨 莉.粒细胞-巨噬细胞集落刺激因子在肿瘤免疫治疗中的作用机制及临床应用进展[J].诊断学理论与实践,2021,20(4):407-413.
[3] Hotchkiss RS,Opal SM.Activating immunity to fight a foe-a new path[J].N Engl J Med,2020,382(13):1270-1272.
[4] Brem H,Howell R,Criscitelli T,et al.Practical application of granulocyte-macrophage colony-stimulating factor(GM-CSF)in patients with wounds[J].Surg Technol Int,2018,32:61-66.
[5] Yan WL,Shen KY,Tien CY,et al.Recent progress in GM-CSF-based cancer immunotherapy[J].Immunotherapy,2017,9(4):347-360.
[6] Van-Overmeire E,Stijlemans B,Heymann F,et al.M-CSF and GM-CSF receptor signaling differentially regulate monocyte maturation and macrophage polarization in the tumor microenvironment[J].Cancer Res,2016,76(1):35-42.
[7] Sun L,Rautela J,Delconte RB,et al.GM-CSF quantity has a selective effect on granulocytic vs.monocyticmyeloid development and function[J].Front Immunol,2018,9:1922.
[8] Dougan M,Dranoff G,Dougan SK.GM-CSF,IL-3,and IL-5 family of cytokines:Regulators of inflammation[J].Immunity, 2019,50(4):796-811.
[9] Nebiker CA,Han J,Eppenberger-Castori S,et al.GM-CSF production by tumor cells is associated with improved survival in colorectal cancer[J].Clin Cancer Res, 2014,20(12):3094-3106.
[10] Finocchiaro LME,Agnetti L,Fondello C,et al.Combination of cytokine-enhanced vaccine and chemo-gene therapy as surgery adjuvant treatments for spontaneous canine melanoma[J].Gene Therapy,2019,26(10-11):418-431.
[11] 张 檬,罗棉兴,陈 国.链霉亲和素及其亲和系统的蛋白质进化[J].中国生物化学与分子生物学报,2019,35(7):722-729.
[12] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[13] Rawla P,Barsouk A.Epidemiology of gastric cancer:Global trends,risk factors and prevention[J].Prz Gastroenterol,2019,14(1):26-38.
[14] Wu AA,Bever KM,Ho WJ,et al.A phase Ⅱ study of allogeneic GM-CSF-Transfected pancreatic tumor vaccine(GVAX)with ipilimumab as maintenance treatment for metastatic pancreatic cancer[J].Clin Cancer Res,2020,26(19):5129-5139.
[15] Cai Z,Xin F,Wei Z,et al.Photodynamic therapy combined with antihypoxic signaling and CpG adjuvant as an in situ tumor vaccine based on metal-organic framework nanoparticles to boost cancer immunotherapy[J].Advanced Healthcare Materials,2020,9(1):e1900996.
[16] 汤佳琦,胡 楠,张竞舟,等.胃癌免疫治疗的研究进展[J].山东医药,2020,60(26):90-93.
[17] 邢续扬,王孝春,何 伟.肿瘤免疫治疗及其药物研发进展[J].中国药科大学学报,2021,52(1):10-19.
[18] 周 锐,马灏川,陈亚栋,等.针灸辅助治疗胃癌现状及展望[J].陕西中医,2021,42(8):1150-1153.
[19] 王 乐.肿瘤免疫疗法及临床应用的研究进展[J].河北医药,2022,44(16):2520-2525.
[20] Kinoshita Y,Xu J,Masuda A,et al.Expression and purification of biologically active human granulocyte-macrophage colony stimulating factor(hGM-CSF)using silkworm-baculovirus expression vector system[J].Protein Expr Purif,2019,159:69-74.
[21] 方虹仪,郭 娜,邢纪斌,等.融合蛋白TAT-RabGEF1原核表达载体的构建及蛋白表达[J].中山大学学报:医学版,2018,39(1):61-67.
[22] 宋志纯,戴 数,王 朋,等.MIP-3α-SA双功能融合蛋白的制备及其生物学功能鉴定[J].温州医科大学学报,2019,49(5):360-366.

备注/Memo

备注/Memo:
基金项目:陕西省重点研发计划项目(2021ZDLSF01-07); 陕西省人民医院领军人才计划项目(2021LJ-02); 北京康盟慈善基金会医学科研发展基金资助项目(7B202010); 陕西省科学技术协会青年人才托举计划项目(SWYY202221)
更新日期/Last Update: 2022-12-28